Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy

Primary squamous cell carcinoma (SCC) of the periampullary area is exceedingly rare. We report a case of a 45-year-old woman who presented with progressive upper abdominal pain and melena. Laboratory testing revealed an elevated level of carcinoembryonic antigen. Esophagogastroduodenoscopy revealed...

Full description

Bibliographic Details
Main Authors: Baoshan Wang, Dazhou Li, Dehua Zeng, Wen Wang, Chuanshen Jiang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1086760/full
_version_ 1797942046533615616
author Baoshan Wang
Dazhou Li
Dehua Zeng
Wen Wang
Wen Wang
Chuanshen Jiang
author_facet Baoshan Wang
Dazhou Li
Dehua Zeng
Wen Wang
Wen Wang
Chuanshen Jiang
author_sort Baoshan Wang
collection DOAJ
description Primary squamous cell carcinoma (SCC) of the periampullary area is exceedingly rare. We report a case of a 45-year-old woman who presented with progressive upper abdominal pain and melena. Laboratory testing revealed an elevated level of carcinoembryonic antigen. Esophagogastroduodenoscopy revealed a very large irregular ulcerated tumor in the periampullary area. Contrast-enhanced computed tomography (CT) of the chest, abdomen, and pelvis, 18 F-fluorodeoxyglucose positron emission tomography/CT, and thin-prep cytologic test excluded metastasis of the primary tumor to the periampullary area from other sites. Immunohistochemistry revealed positive p40 and cytokeratin (CK)5/6, indicating SCC. The expression of programmed cell death-ligand 1 (PD-L1) in tumor cells was upregulated, and the patient responded well to chemotherapy combined with immunotherapy. To the best of our knowledge, this is the first reported case of advanced primary SCC in the periampullary area with high expression of PD-L1.
first_indexed 2024-04-10T20:01:28Z
format Article
id doaj.art-6f00cc38f36d4fd2a330ec3323a0da40
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T20:01:28Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-6f00cc38f36d4fd2a330ec3323a0da402023-01-27T04:38:27ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-01-011410.3389/fimmu.2023.10867601086760Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapyBaoshan Wang0Dazhou Li1Dehua Zeng2Wen Wang3Wen Wang4Chuanshen Jiang5Department of Gastroenterology, 900THHospital of Joint Logistics Support Force, Fujian Medical University, Fuzhou, ChinaDepartment of Gastroenterology, 900THHospital of Joint Logistics Support Force, Fujian Medical University, Fuzhou, ChinaDepartment of Pathology, 900THHospital of Joint Logistics Support Force, Fujian Medical University, Fuzhou, ChinaDepartment of Gastroenterology, 900THHospital of Joint Logistics Support Force, Fujian Medical University, Fuzhou, ChinaDepartment of Gastroenterology, 900THHospital of Joint Logistics Support Force, Oriental Hospital Affiliated to Xiamen University, Fuzhou, ChinaDepartment of Gastroenterology, 900THHospital of Joint Logistics Support Force, Fujian Medical University, Fuzhou, ChinaPrimary squamous cell carcinoma (SCC) of the periampullary area is exceedingly rare. We report a case of a 45-year-old woman who presented with progressive upper abdominal pain and melena. Laboratory testing revealed an elevated level of carcinoembryonic antigen. Esophagogastroduodenoscopy revealed a very large irregular ulcerated tumor in the periampullary area. Contrast-enhanced computed tomography (CT) of the chest, abdomen, and pelvis, 18 F-fluorodeoxyglucose positron emission tomography/CT, and thin-prep cytologic test excluded metastasis of the primary tumor to the periampullary area from other sites. Immunohistochemistry revealed positive p40 and cytokeratin (CK)5/6, indicating SCC. The expression of programmed cell death-ligand 1 (PD-L1) in tumor cells was upregulated, and the patient responded well to chemotherapy combined with immunotherapy. To the best of our knowledge, this is the first reported case of advanced primary SCC in the periampullary area with high expression of PD-L1.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1086760/fullperiampullaryprogrammed cell death-ligand 1primaryimmunotherapysintilimabsquamous cell carcinoma
spellingShingle Baoshan Wang
Dazhou Li
Dehua Zeng
Wen Wang
Wen Wang
Chuanshen Jiang
Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
Frontiers in Immunology
periampullary
programmed cell death-ligand 1
primary
immunotherapy
sintilimab
squamous cell carcinoma
title Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
title_full Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
title_fullStr Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
title_full_unstemmed Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
title_short Case report: Advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death-ligand 1 expression and response to sintilimab immunotherapy
title_sort case report advanced primary squamous cell carcinoma in the periampullary area with upregulation of programmed cell death ligand 1 expression and response to sintilimab immunotherapy
topic periampullary
programmed cell death-ligand 1
primary
immunotherapy
sintilimab
squamous cell carcinoma
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1086760/full
work_keys_str_mv AT baoshanwang casereportadvancedprimarysquamouscellcarcinomaintheperiampullaryareawithupregulationofprogrammedcelldeathligand1expressionandresponsetosintilimabimmunotherapy
AT dazhouli casereportadvancedprimarysquamouscellcarcinomaintheperiampullaryareawithupregulationofprogrammedcelldeathligand1expressionandresponsetosintilimabimmunotherapy
AT dehuazeng casereportadvancedprimarysquamouscellcarcinomaintheperiampullaryareawithupregulationofprogrammedcelldeathligand1expressionandresponsetosintilimabimmunotherapy
AT wenwang casereportadvancedprimarysquamouscellcarcinomaintheperiampullaryareawithupregulationofprogrammedcelldeathligand1expressionandresponsetosintilimabimmunotherapy
AT wenwang casereportadvancedprimarysquamouscellcarcinomaintheperiampullaryareawithupregulationofprogrammedcelldeathligand1expressionandresponsetosintilimabimmunotherapy
AT chuanshenjiang casereportadvancedprimarysquamouscellcarcinomaintheperiampullaryareawithupregulationofprogrammedcelldeathligand1expressionandresponsetosintilimabimmunotherapy